July 06, 2010
Although the going rate for a commodity server might be going down a little these days, if it's 25 that you're looking to buy, chances are you've at least glanced at the possibility of outsourcing to the cloud. Pharmaceutical giant Eli Lilly did just this to handle one case of drug development data analysis, according to Accenture as quoted in Forbes magazine. Eli Lilly's public statement about using the cloud to handle certain applications is good news for other pharma companies looking to do the same since this is one area where widespread adoption has been slow to catch on, in part because of compliance and security concerns (look to Bruce Maches for more on that topic). This is an important piece of news as well because when pharma has used the cloud, it's more often for the purposes of drug discovery, not clinical research.
Full story at FierceBiotechIT
10/30/2013 | Cray, DDN, Mellanox, NetApp, ScaleMP, Supermicro, Xyratex | Creating data is easy… the challenge is getting it to the right place to make use of it. This paper discusses fresh solutions that can directly increase I/O efficiency, and the applications of these solutions to current, and new technology infrastructures.
10/01/2013 | IBM | A new trend is developing in the HPC space that is also affecting enterprise computing productivity with the arrival of “ultra-dense” hyper-scale servers.
Ken Claffey, SVP and General Manager at Xyratex, presents ClusterStor at the Vendor Showdown at ISC13 in Leipzig, Germany.
Join HPCwire Editor Nicole Hemsoth and Dr. David Bader from Georgia Tech as they take center stage on opening night at Atlanta's first Big Data Kick Off Week, filmed in front of a live audience. Nicole and David look at the evolution of HPC, today's big data challenges, discuss real world solutions, and reveal their predictions. Exactly what does the future holds for HPC?